Sleep Medicine
Volume 7, Issue 4 , Pages 350-356 , June 2006

Social-cognitive correlates of CPAP adherence in experienced users

  • Carl J. Stepnowsky

      Affiliations

    • Health Services Research and Development Unit (111N-1), Veteran Affairs San Diego Healthcare System, 3350 La Jolla Village Drive, San Diego, CA 92161, USA
    • Department of Psychiatry, University of California, San Diego, CA, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 858 552 8585x5948; fax: +1 858 552 4321.
    • ,
  • Matthew R. Marler

      Affiliations

    • Department of Psychiatry, University of California, San Diego, CA, USA
    • ,
  • Joe Palau

      Affiliations

    • Health Services Research and Development Unit (111N-1), Veteran Affairs San Diego Healthcare System, 3350 La Jolla Village Drive, San Diego, CA 92161, USA
    • ,
  • J. Annette Brooks

      Affiliations

    • Behavioral Medicine Service, New Mexico Veterans Affairs Health Care System, Albuquerque, NM, USA

Received 22 July 2005 ,Revised 27 October 2005 ,Accepted 6 November 2005.

References 

  1. Bassiri AG, Guilleminault C. Clinical features and evaluation of obstructive sleep apnea-hypopnea syndrome. In:  Dement WC editors. Principle and practice of sleep medicine. Philadelphia, PA: Saunders; 2000;p. 869–878
  2. Young T, Peppard P, Palta M, et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med. 1997;157(15):1746–1752
  3. Young T, Blustein J, Finn L, Palta M. Sleep-disordered breathing and motor vehicle accidents in a population-based sample of employed adults. Sleep. 1997;20(8):608–613
  4. He J, Kryger MH, Zorick FJ, et al. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest. 1988;94(1):9–14
  5. Partinen M, Jamieson A, Guilleminault C. Long-term outcome for obstructive sleep apnea syndrome patients. Mortal Chest. 1988;94(6):1200–1204
  6. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. J Am Med Assoc. 2003;289(19):2560–2572
  7. Sullivan CE, Issa FG, Berthon-Jones M, Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet. 1981;1(8225):862–865
  8. Loube DI, Gay PC, Strohl KP, et al. Indications for positive airway pressure treatment of adult obstructive sleep apnea patients: a consensus statement. Chest. 1999;115(3):863–866
  9. Patel SR, White DP, Malhotra A, et al. Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis. Arch Intern Med. 2003;163(5):565–571
  10. Wright J, Johns R, Watt I, et al. Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: a systematic review of the research evidence. B Med J. 1997;314(7084):851–860
  11. McArdle N, Douglas NJ. Effect of continuous positive airway pressure on sleep architecture in the sleep apnea-hypopnea syndrome: a randomized controlled trial. Am J Respir Crit Care Med. 2001;164(8 Pt 1):1459–1463
  12. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet. 2002;359(9302):204–210
  13. Bahammam AS, Delaive K, Ronald J, et al. Health care utilization in males with obstructive sleep apnea syndrom two years after diagnosis and treatment. Sleep. 1999;22:740–747
  14. Kribbs NB, Pack AI, Kline LR, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis. 1993;147(4):887–895
  15. Reeves-Hoche MK, Meck R, Zwillich CW. Nasal CPAP: an objective evaluation of patient compliance. Am J Respir Crit Care Med. 1994;149(1):149–154
  16. Stepnowsky C, Marler MR, Ancoli-Israel S. Determinants of nasal CPAP compliance. Sleep Med. 2002;3(3):239–247
  17. Collard P, Pieters T, Aubert G, et al. Compliance with nasal CPAP in obstructive sleep apnea patients. Sleep Med Rev. 1997;1:33–44
  18. Engleman HM, Wild MR. Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS). Sleep Med Rev. 2003;7(1):81–99
  19. Kingshott RN, Vennelle M, Hoy CJ, et al. Predictors of improvements in daytime function outcomes with CPAP therapy. Am J Respir Crit Care Med. 2000;161(3 Pt 1):866–871
  20. Pelletier-Fleury N, Rakotonanahary D, Fleury B. The age of other factors in the evaluation of compliance with nasal continuous positive airway pressure for obstructive sleep apnea syndrome: a cox's proportional hazard analysis. Sleep Med. 2001;2:225–232
  21. Wild MR, Engleman HM, Douglas NJ, Espie CA. Can psychological factors help us to determine adherence to CPAP? A prospective study. Eur Respir J. 2004;24(3):461–465
  22. Bandura A. Social foundations of thought and action. A social cognitive theory. Englewood Cliffs, NJ: Prentice Hall; 1986;
  23. Prochaska JO, Redding CA, Evers KE. The transtheoreticl model and stages of change. In:  Glanz K,  Lewis FM,  Rimer BK editor. Health behavior and health education. San Francisco, CA: Josey-Bass Publishers; 1997;
  24. Edinger JD, Carwile S, Miller P, Mayti C. Psychological status, syndromatic measures, and compliance with nasal CPAP therapy for sleep apnoea. Percept Mot Skills. 1994;78:1116–1118
  25. Hui DS, Choy DK, Li TS, et al. Determinants of continuous positive airway pressure compliance in a group of Chinese patients with obstructive sleep apnea. Chest. 2001;120(1):170–176
  26. Rauscher H, Formanek D, Popp W, Zwick H. Self-reported vs measured compliance with nasal CPAP for obstructive sleep apnea. Chest. 1993;103(6):1675–1680
  27. Hoy CJ, Vennelle M, Kingshott RN, et al. Can intensive support improve continuous positive airway pressure use in patients with the sleep apnea/hypopnea syndrome?. Am J Respir Crit Care Med. 1999;159(4 Pt 1):1096–1100
  28. Likar L, Panciera T, Erickson A, Rounds S. Group education sessions and compliance with nasal CPAP therapy. Chest. 1997;111(5):1273–1277
  29. Hui DS, Chan JK, Choy DK, et al. Effects of augmented continuous positive airway pressure education and support on compliance and outcome in a Chinese population. Chest. 2000;117(5):1410–1416
  30. Aloia MS, Arnedt JT, Riggs RL, et al. Clinical management of poor adherence to CPAP: motivational enhancement. Behav Sleep Med. 2004;2(4):205–222
  31. Aloia MS, Di Dio L, Ilniczky N, et al. Improving compliance with nasal CPAP and vigilance in older adults with OAHS. Sleep Breath. 2001;5(1):13–21
  32. Stepnowsky CJ, Moore PJ. Nasal CPAP treatment for obstructive sleep apnea: developing a new perspective on dosing strategies and compliance. J Psychosom Res. 2003;54(6):599–605
  33. Kryger M. Management of obstructive sleep apnea-hypopnea syndrom: overview. In:  Dement WC editors. Principles and practice of sleep medicine. Philadelphia, PA: Saunders; 2000;p. 940–954
  34. Kribbs NB, Pack AI, Kline LR, et al. Effects of one night without nasal CPAP treatment on sleep and sleepiness in patients with obstructive sleep apnea. Am Rev Respir Dis. 1993;147(5):1162–1168
  35. Sforza E, Lugaresi E. Daytime sleepiness and nasal continuous positive airway pressure therapy in obstructive sleep apnea syndrome patients: effects of chronic treatment and 1-night therapy withdrawal. Sleep. 1995;18(3):195–201
  36. Collop NA, Block AJ, Hellard D. The effect of nightly nasal CPAP treatment on underlying obstructive sleep apnea and pharyngeal size. Chest. 1991;99(4):855–860
  37. Hers V, Liistro G, Dury M, et al. Residual effect of nCPAP applied for part of the night in patients with obstructive sleep apnoea. Eur Respir J. 1997;10(5):973–976
  38. Stepnowsky C, Dimsdale J. Dose-response relationship between CPAP compliance and measures of sleep apnea severity. Sleep Med. 2002;3:329–334
  39. Engleman HM, Martin SE, Deary IJ, Douglas NJ. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet. 1994;343(8897):572–575
  40. Engleman HM, Martin SE, Deary IJ, Douglas NJ. Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome. Thorax. 1997;52(2):114–119
  41. Stradling JR, Davies RJ. Is more NCPAP better?. Sleep. 2000;23(Suppl. 4):S150–S153
  42. Zozula R, Rosen R. Compliance with continuous positive airway pressure therapy: assessing and improving treatment outcomes. Curr Opin Pulm Med. 2001;7(6):391–398
  43. Gifford AL, Groessl EJ. Chronic disease self-management and adherence to HIV medications. J Acq Immu Def Syn. 2002;31(Suppl. 3):S163–S166
  44. Lorig KR, Holman H. Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med. 2003;26(1):1–7
  45. Lorig KR, Ritter P, Stewart AL, et al. Chronic disease self-management program: 2-year health status and health care utilization outcomes. Med Care. 2001;39(11):1217–1223
  46. Von Korff M, Moore JE, Lorig K, et al. A randomized trial of a lay person-led self-management group intervention for back pain patients in primary care. Spine. 1998;23(23):2608–2615

PII: S1389-9457(05)00269-8

doi: 10.1016/j.sleep.2005.11.004

Sleep Medicine
Volume 7, Issue 4 , Pages 350-356 , June 2006

Article Tools

* Image Usage & Resolution